Fineline Cube

Follow:
14778 Articles
Sunshine Guojian Pharma Reports Q3 Revenue Growth and Advances in Clinical Trials
Company

Sunshine Guojian Pharma Reports Q3 Revenue Growth and Advances in Clinical Trials

LINDIS Biotech's Catumaxomab Receives Positive Opinion from EMA's COMP for Malignant Ascites Treatment
CompanyDrug

LINDIS Biotech’s Catumaxomab Receives Positive Opinion from EMA’s COMP for Malignant Ascites Treatment

China's NMPA Launches Pilot Program for Phased Manufacturing of Biological Products
Policy / Regulatory

China’s NMPA Launches Pilot Program for Phased Manufacturing of Biological Products

Beijing Biostar Technologies Goes Public in Hong Kong to Fund Cancer Drug Development
CompanyDeals

Beijing Biostar Technologies Goes Public in Hong Kong to Fund Cancer Drug Development

China Grand Pharmaceutical Receives NMPA Approval for Innovative Adjustable Thrombectomy Stent
CompanyMedical Device

China Grand Pharmaceutical Receives NMPA Approval for Innovative Adjustable Thrombectomy Stent

Grifols Partners with BARDA to Develop Treatment for Sulfur Mustard Ocular Injury
CompanyDeals

Grifols Partners with BARDA to Develop Treatment for Sulfur Mustard Ocular Injury

Hunan Province Launches Pilot Program for Retail Sales of VBP Drugs with Strict Guidelines
Policy / Regulatory

Hunan Province Launches Pilot Program for Retail Sales of VBP Drugs with Strict Guidelines

Walvax Biotechnology's Weuphoria Vaccine Approved in Oman for Pediatric Pneumococcal Infections
CompanyDrug

Walvax Biotechnology’s Weuphoria Vaccine Approved in Oman for Pediatric Pneumococcal Infections

German Endoscope Maker KARL STORZ Secures Marketing Approval for Disposable Ureteroscope in China
CompanyMedical Device

German Endoscope Maker KARL STORZ Secures Marketing Approval for Disposable Ureteroscope in China

LENZ Therapeutics' Presbyopia Therapy LNZ100 Accepted for FDA Review
CompanyDrug

LENZ Therapeutics’ Presbyopia Therapy LNZ100 Accepted for FDA Review

Company

Macrolux Raises Over RMB 100 Million in Series B Financing

AstraZeneca's Wainzua Earns CHMP Nod for hATTR-PN Treatment in the EU
CompanyDrug

AstraZeneca’s Wainzua Earns CHMP Nod for hATTR-PN Treatment in the EU